Medical News

RSS

BioTrends Research Group report provides in-depth view of kidney transplantation market

BioTrends Research Group, Inc. recently published its TreatmentTrends: Kidney Transplantation report. This report is based on online survey results from over 150 physicians (general nephrologists, transplant nephrologists and transplant surgeons). It provides an in-depth view of the kidney transplantation market, including the roles of the various specialties, promotional efforts and sales representative messaging, barriers to kidney transplant, the care of post-transplant patients, and current and projected use of immunosuppressive agents for induction, maintenance and acute rejection.

26 Aug 2010

Queen West Village Family Health Team to provide primary health care for community

Toronto's Queen West neighbourhood and the province's health care system alike will benefit from the August 24 announcement that a Family Health Team will be housed locally at the Centre for Addiction and Mental Health.

26 Aug 2010

DTC grants eligibility status to Medisafe 1 Technologies

Medisafe 1 Technologies Corp., a developer of a U.S. patented technology that physically prevents unauthorized administration of prescription medications, announced today that the company has been granted eligibility status by the Depository Trust Company. The DTC provides banks, brokerage firms and other institutions with an efficient means of moving securities and settling trades electronically.

26 Aug 2010

New book on fighting hair loss

World renowned hair loss expert, Dr. Larry Shapiro, announced the release of his new book, Fight Hair Loss and Win! and says that Elin Nordegren is not alone when it comes to hair loss as a result of stress. Shapiro says millions of women and men are experiencing the same and that heightened levels of stress, popular nutritional supplements, hormonal imbalances and many other unsuspecting factors are now linked to hair loss.

26 Aug 2010

Bio-Reference Laboratories third-quarter revenues increase 25% to $121,719

Bio-Reference Laboratories, Inc. (Except for Per Share Data or where otherwise noted, numbers are in thousands) announced that the Company recorded current quarter revenues of $121,719, the best ever quarter in terms of revenues in corporate history and an increase of 25% over the $97,424 recorded in the third quarter, fiscal year 2009.

26 Aug 2010

Preferred Imaging installs Naviscan Positron Emission Mammography scanner in new Plano facility

Preferred Imaging Centers has installed the Naviscan PEM scanner into its newest facility in Plano, TX, adding a dedicated breast imaging modality to its array of diagnostic tools. PEM (Positron Emission Mammography) scanners are high-resolution breast PET systems that show the location as well as the metabolic phase of a lesion. The metabolic view assists physicians in making the optimal patient care decision by providing an unprecedented ability to distinguish between benign and malignant lesions, what researchers term “specificity.”

26 Aug 2010

Xcellerex, SK Chemicals sign memorandum of understanding to expand vaccine business in Korea

Xcellerex, Inc. announced today that it has signed a memorandum of understanding with SK Chemicals, Co., Ltd., one of South Korea's largest industrial groups, for an alliance to develop and commercialize SK-developed vaccines with Xcellerex's FlexFactory biomanufacturing platform. The companies expect to define specific terms of the alliance in the coming months.

26 Aug 2010

First World Congress on Ergothioneine to be held in Los Angeles, California in July 2011

OXIS INTERNATIONAL, INC. is proud to announce that it has initiated active planning for the First World Congress on Ergothioneine, to be held in Los Angeles, California in July 2011 (the specific date will be announced at a later date).

26 Aug 2010

maxIT Healthcare ranked number 3264 on Inc. 5000 list of fastest growing private companies

maxIT Healthcare, a leading professional consulting services company for healthcare providers, has been recognized by Inc. magazine on its third annual Inc. 5000 list of the nation's fastest growing private companies. With three year sales growth of over 59%, maxIT was ranked number 3264 on the list. This is the second consecutive year that maxIT has made the list.

26 Aug 2010

Sermo report highlights physician opinions about investigational oral antiplatelet treatment for ACS

Sermo, the world's largest online community for physicians, today announced a free Sermo Report titled, "FDA Committee Recommends Approval for Ticagrelor." The report covers physician opinions about the introduction of an investigational oral antiplatelet treatment for acute coronary syndrome.

26 Aug 2010

FDA accepts Sanofi Pasteur's Menactra vaccine sBLA for active immunization of infants and toddlers

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.

26 Aug 2010

Medtronic Ablation Frontiers Cardiac Ablation System receives Health Canada approval

Medtronic, Inc. today announced it received Health Canada approval for the Medtronic Ablation Frontiers Cardiac Ablation System, a novel radiofrequency ablation technology for the treatment of atrial fibrillation. AF is the most common heart arrhythmia that affects more than 250,000 Canadians and seven million people worldwide.

26 Aug 2010

NeoPharm second-quarter net loss decreases to $0.8 million

NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for various forms of cancer and other diseases, today announced its second quarter 2010 financial results.

26 Aug 2010

DMAHS awards four-year Medicaid utilization review contract to Permedion

HMS announced today that the State of New Jersey Department of Human Services Division of Medical Assistance and Health Services has awarded a contract to Permedion, Inc., HMS's wholly owned subsidiary, to conduct utilization reviews, medical necessity audits, and Diagnosis Related Group validations of inpatient hospital medical services provided and billed for Medicaid beneficiaries.

26 Aug 2010

DePuy Orthopaedics announces voluntary recall of ASR XL Acetabular and Hip Resurfacing systems

DePuy Orthopaedics, Inc., announced it is voluntarily recalling the ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System used in hip replacement surgery due to the number of patients who required a second hip replacement procedure, called a revision surgery.

26 Aug 2010

Dose-defining Phase IIa trial of CXL-1020 initiated for treating patients with ADHF

Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing therapeutic agents for the treatment of cardiovascular disease, today announced that it has initiated a dose-defining Phase IIa trial of its lead drug candidate, CXL-1020, for the treatment of patients with acute decompensated heart failure.

26 Aug 2010

FORTUNE ranks China-Biotics 62nd on 2010 'Fastest-Growing Companies' list

China-Biotics, Inc., a leading developer, manufacturer and distributor of probiotics products in China, today announced that the Company is ranked 62nd on FORTUNE's 2010 "Fastest-Growing Companies" list.

26 Aug 2010

Alexza Pharmaceuticals licenses Staccato nicotine technology to Cypress Bioscience

Alexza Pharmaceuticals, Inc. announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, mimicking the nicotine effects of smoking without the harmful side effects associated with cigarettes.

26 Aug 2010

Aon Consulting survey finds increase in monthly COBRA contributions for terminated employees

As the national unemployment rate continues to hover around 10 percent, health care costs for those jobless Americans have seen a year-over-year increase, according to Aon Consulting, the global benefits and human capital consulting business of Aon Corporation.

26 Aug 2010

Restat announces signing of PEBA as latest Align cost-plus pricing model client

Restat, the nation's largest independent pharmacy benefits manager has announced the signing of the Public Employee Benefits Alliance as its latest Align cost-plus pricing model client. PEBA, an organization formed by several Texas government employers, cooperatively purchases employee benefits -- including health care benefits -- on behalf of the local government entities.

26 Aug 2010

Medical News

BioTrends Research Group report provides in-depth view of kidney transplantation market

Queen West Village Family Health Team to provide primary health care for community

DTC grants eligibility status to Medisafe 1 Technologies

New book on fighting hair loss

Bio-Reference Laboratories third-quarter revenues increase 25% to $121,719

Preferred Imaging installs Naviscan Positron Emission Mammography scanner in new Plano facility

Xcellerex, SK Chemicals sign memorandum of understanding to expand vaccine business in Korea

First World Congress on Ergothioneine to be held in Los Angeles, California in July 2011

maxIT Healthcare ranked number 3264 on Inc. 5000 list of fastest growing private companies

Sermo report highlights physician opinions about investigational oral antiplatelet treatment for ACS

FDA accepts Sanofi Pasteur's Menactra vaccine sBLA for active immunization of infants and toddlers

Medtronic Ablation Frontiers Cardiac Ablation System receives Health Canada approval

NeoPharm second-quarter net loss decreases to $0.8 million

DMAHS awards four-year Medicaid utilization review contract to Permedion

DePuy Orthopaedics announces voluntary recall of ASR XL Acetabular and Hip Resurfacing systems

Dose-defining Phase IIa trial of CXL-1020 initiated for treating patients with ADHF

FORTUNE ranks China-Biotics 62nd on 2010 'Fastest-Growing Companies' list

Alexza Pharmaceuticals licenses Staccato nicotine technology to Cypress Bioscience

Aon Consulting survey finds increase in monthly COBRA contributions for terminated employees

Restat announces signing of PEBA as latest Align cost-plus pricing model client

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News